MARKET COMPOSITE
SNDL - Sundial Growers Inc7:59:51 PM 4/19/2024
Price
$1.88
+ 0.05 (2.73%)
Sundial Growers Inc. engages in the production, distribution, and sale of cannabis products for the adult-use market It is also involved in the production, distribution, and sale of ornamental plants and herbs in the United Kingdom. The company offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. Sundial Growers Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news

    SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") is pleased to announce that Zach George, the Company's Chief Executive Officer, and Alberto Paredero, Chief Financial Officer, will be participating in several upcoming investor and cannabis conferences, including the International Cannabis Business Conference Berlin B2B and Benzinga Cannabis Capital Conference in Miami, Florida this month.

    SNDL Inc. (Nasdaq: SNDL) ("SNDL") and Nova Cannabis Inc. (TSX: NOVC) ("Nova") announced today that SNDL has agreed to assign its rights to own or operate four Dutch Love stores (the "Dutch Love Stores") to Nova (the "Assignment").

    In investing, the allure of penny stocks attracts seasoned investors and newcomers alike. Small-cap stocks often trade on mere cents, but they can potentially yield massive returns. They are serving as the groundwork for the next generation of millionaire-makers. Within this space, three standout entities emerge as captivating protagonists. The first one orchestrates strategic acquisitions to boost its reach in the companion animal healthcare market. The second booms towards profitability throug

    Why SNDL Rallied Last Week03-31-2024 22:25:00 PM

    SNDL carried earnings momentum into the week with positive news flow on cannabis legalization.

    The sector has more economic power and public support than some might realize.

    When Joe Biden assumed power in January 2021, cannabis stocks skyrocketed. The reason was hopes of federal level legalization. With 2024 being an election year, there seems to be renewed excitement related to cannabis stocks. Germany’s Federal Council recently approved the cannabis bill for personal use. This has triggered renewed interest in the sector as it finally seems that regulatory headwinds will wane. In the United States, Kamala Harris recently urged the Drug Enforcement Administration

    Three out of five voters surveyed would like marijuana to be cheaper.

    SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the full year and fourth quarter ended December 31, 2023. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated.

    Numbers frequently take center stage in the stock market’s maze. However, every figure has a story of strategy, ingenuity, and resiliency behind it. Here are the qualitative subtleties that characterize the success tales of three often overlooked stocks. Start with the first one, a digital trailblazer with millions of fans thanks to its array of cutting-edge technologies. The company is in a very competitive state based on user-centric design and advancement, which is evident in the sheer size o

    In the stock market, the clamor for attention often focuses on the big players. Under-the-radar stocks are waiting to be discovered. Three companies can transform a mere $10K investment into a staggering $1 million windfall by 2028. It sounds like a fantasy. However, these stocks offer possibilities lurking just beneath the surface. These tech titans and pharmaceutical giants harbor immense potential for high returns. The first one stands at the forefront of the cannabis industry, armed with sol